Association of the KDIGO Risk Classification with the Prevalence of Heart Failure in Patients with Type 2 Diabetes.

dc.contributor.authorGimeno-Orna, José Antonio
dc.contributor.authorRodríguez-Padial, Luis
dc.contributor.authorAnguita-Sánchez, Manuel
dc.contributor.authorBarrios, Vivencio
dc.contributor.authorMuñiz, Javier
dc.contributor.authorPérez, Antonio
dc.date.accessioned2025-01-07T13:32:26Z
dc.date.available2025-01-07T13:32:26Z
dc.date.issued2021-10-09
dc.description.abstractThe objectives of this study were to determine the main characteristics associated with the presence of heart failure (HF) in patients with type 2 diabetes (T2DM), and specifically to assess the association of the risk classification proposed by the Kidney Disease Improving Global Outcomes (KDIGO) guidelines with HF. The DIABET-IC study is a multicentre, observational, prospective and analytical study in T2DM patients recruited in Spanish hospitals. This work, which features a cross-sectional design, has been conducted with the data obtained at the inclusion visit. The main dependent variable analysed was the presence of HF. The predictive variables evaluated were the demography, clinic, laboratory testing (including natriuretic peptides) and echocardiography. Patients were classified according to the number of vascular territories with atherosclerotic involvement and the KDIGO risk category. Multivariate logistic regression models were performed to determine the risk posed by the various baseline variables to present HF at the time of study inclusion. The study included 1517 patients from 58 hospitals, with a mean age of 67.3 (standard deviation (SD): 10) years, out of which 33% were women. The mean DM duration was 14 (SD: 11) years. The prevalence of HF was 37%. In a multivariate analysis, the independent predictors of HF were increased age (odds ratio (OR) per 1 year = 1.02; p = 0.006), decreased systolic blood pressure (OR per 1 mmHg = 0.98; p 1 territory = 2.39; p = 0.02 and p
dc.identifier.doi10.3390/jcm10204634
dc.identifier.issn2077-0383
dc.identifier.pmcPMC8541098
dc.identifier.pmid34682756
dc.identifier.pubmedURLhttps://pmc.ncbi.nlm.nih.gov/articles/PMC8541098/pdf
dc.identifier.unpaywallURLhttps://www.mdpi.com/2077-0383/10/20/4634/pdf?version=1634020229
dc.identifier.urihttps://hdl.handle.net/10668/25629
dc.issue.number20
dc.journal.titleJournal of clinical medicine
dc.journal.titleabbreviationJ Clin Med
dc.language.isoen
dc.organizationSAS - Hospital Universitario Reina Sofía
dc.organizationInstituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)
dc.pubmedtypeJournal Article
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectKDIGO risk category
dc.subjectcardiovascular disease
dc.subjectheart failure
dc.subjecttype 2 diabetes
dc.titleAssociation of the KDIGO Risk Classification with the Prevalence of Heart Failure in Patients with Type 2 Diabetes.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number10

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
PMC8541098.pdf
Size:
863.2 KB
Format:
Adobe Portable Document Format